Francisco Abad-Santos (F Abad-Santos)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 77

Top Venues

Pharmaceutics

Journal of personalized medicine

Clinical and translational science

Advances in therapy

Universidad Autónoma de Madrid Facultad de Medicina

Universidad Autonoma de Madrid Facultad de Medicina (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Autónoma de Madrid Facultad de Medicina Sep 27 2018

Spain

Professor :: Pharmacology

Universidad Autonoma de Madrid Facultad de Medicina - Sep 27 2018

Spain

Associate professor :: Pharmacology and Therapeutics

Education History

Universidad Autonoma de Madrid Facultad de Medicina - Jun 24 1994

Spain

PHD :: Pharmacology and Therapeutics

Publications

Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio José Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona Francés, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander Vaquero, Pablo Zubiaur
Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 25 (7) (2024)
Houwaida Abbes, Pablo Zubiaur, Paula Soria-Chacartegui, Tamara de la Torre, Gonzalo Villapalos-García, Carmen Candau, Andrea Rodríguez-Lopez, Eva González-Iglesias, Marina Aldama, Marcos Navares-Gomez, Asma Omezzine, Dolores Ochoa, Francisco Abad-Santos
SLCO1B1 and ABCG2 genotype-informed phenotypes are related to variation in ramipril exposure. Basic & clinical pharmacology & toxicology (2024)
Paula Soria-Chacartegui, Patricia Cendoya-Ramiro, Eva González-Iglesias, Samuel Martín-Vílchez, Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Manuel Román, Sergio Luquero-Bueno, Dolores Ochoa, Francisco Abad-Santos
Genetic Variation in CYP2D6 , UGT1A4 , SLC6A2 and SLCO1B1 Alters the Pharmacokinetics and Safety of Mirabegron. Pharmaceutics 16 (8) (2024)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science 17 (1) (2024)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science 17 (1) (2024)
Paula Soria-Chacartegui, Patricia Cendoya-Ramiro, Eva González-Iglesias, Samuel Martín-Vílchez, Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Manuel Román, Sergio Luquero-Bueno, Dolores Ochoa, Francisco Abad-Santos
Genetic Variation in CYP2D6 , UGT1A4 , SLC6A2 and SLCO1B1 Alters the Pharmacokinetics and Safety of Mirabegron. Pharmaceutics 16 (8) (2024)
Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa
Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa
Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa
Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Houwaida Abbes, Pablo Zubiaur, Paula Soria-Chacartegui, Tamara de la Torre, Gonzalo Villapalos-García, Carmen Candau, Andrea Rodríguez-Lopez, Eva González-Iglesias, Marina Aldama, Marcos Navares-Gomez, Asma Omezzine, Dolores Ochoa, Francisco Abad-Santos
SLCO1B1 and ABCG2 genotype-informed phenotypes are related to variation in ramipril exposure. Basic & clinical pharmacology & toxicology 135 (3) (2024)
Eva González-Iglesias, Francisco Abad-Santos
Update on the PriME-PGx initiative: evolution of pharmacogenetics in daily clinical practice. Pharmacogenomics (2024)
Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio José Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona Francés, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander Vaquero, Pablo Zubiaur
Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 25 (7) (2024)
Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio José Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona Francés, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander Vaquero, Pablo Zubiaur
Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 25 (7) (2024)
Pablo Zubiaur, James Steven Leeder, Francisco Abad-Santos, Andrea Gaedigk
Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?" Clinical pharmacology and therapeutics (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Marcos Navares-Gómez, Houwaida Abbes, Gonzalo Villapalos-García, Alejandro de Miguel, Eva González-Iglesias, Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Samuel Martín-Vilchez, Sergio Luquero-Bueno, Manuel Román, Francisco Abad-Santos
Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide. International journal of molecular sciences 24 (20) (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina P Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Paloma Moraga Alapont, Paula Prieto, Almari Conradie, Majda Benhayoun, Vicki Rousell, Maria Davy, Uwe Fuhr, Rosa Antonijoan Arbos, Francisco Abad-Santos, Antonio Portolés, Jolanda Van Duinen, Antonio J Carcas, Alberto M Borobia, null null
Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units. Clinical and translational science (2023)
Victor Mangas Sanjuan, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, Alfredo Garcia-Arieta
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State-A Case Study. Pharmaceutics 15 (2) (2023)
Miriam Saiz-Rodriguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina P Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Pablo Zubiaur, Paula Soria-Chacartegui, Erin C Boone, Bhagwat Prasad, Jean Dinh, Wendy Y Wang, Santiago Zugbi, Andrea Rodríguez-Lopez, Eva González-Iglesias, James Steven Leeder, Francisco Abad-Santos, Andrea Gaedigk
Impact of CYP2C:TG haplotype on CYP2C19 substrates clearance in vivo, protein content and in vitro activity. Clinical pharmacology and therapeutics (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina P Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Victor Mangas Sanjuan, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, Alfredo Garcia-Arieta
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State-A Case Study. Pharmaceutics 15 (2) (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina P Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science (2023)
Gonzalo Villapalos-García, Pablo Zubiaur, Cristina Marián-Revilla, Paula Soria-Chacartegui, Marcos Navares-Gómez, Gina P Mejía-Abril, Andrea Rodríguez-Lopez, Eva González-Iglesias, Samuel Martín-Vílchez, Manuel Román, Dolores Ochoa, Francisco Abad-Santos
Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride. Journal of personalized medicine 13 (11) (2023)
Sarahí Valdez-Acosta, Pablo Zubiaur, Miguel Angel Casado, Jesús Novalbos, Ana Casajús, Diana Campodónico, Itziar Oyagüez, Francisco Abad-Santos
Preemptive TPMT Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases. Journal of personalized medicine 13 (8) (2023)
Victor Mangas Sanjuan, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, Alfredo Garcia-Arieta
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State-A Case Study. Pharmaceutics 15 (2) (2023)
Miriam Saiz-Rodriguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina P Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science (2023)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science (2023)
Miriam Saiz-Rodriguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina P Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Jaime Monserrat Villatoro, Gina Mejía-Abril, Lucía Díaz García, Pablo Zubiaur, María Jiménez González, Guillermo Fernandez Jimenez, Inés Cancio, José Ramón Arribas, Carmen Suarez Fernández, Jesús Mingorance, Julio García-Rodríguez, José Ramón Villagrasa Ferrer, Antonio J Carcas, Jesús Frías, Francisco Abad-Santos, Alberto M Borobia, Elena Ramírez García, null On Behalf Of The Covid Hulp Working Group And Other Collaborators From Hospital Universitario de la Princesa
A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals (Basel, Switzerland) 15 (1) (2022)
Álvaro Pinto-Merino, Jorge Labrador-Gomez, Pablo Zubiaur, Raquel Alcaraz, Maria José Herrero, Pau Montesinos, Francisco Abad-Santos, Miriam Saiz-Rodriguez
Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. Pharmaceutics 14 (3) (2022)
Ana Casajús, Pablo Zubiaur, Marta Méndez, Diana Campodónico, Antía Gómez, Marcos Navares-Gómez, Gonzalo Villapalos-García, Paula Soria-Chacartegui, Jesús Novalbos, Manuel Román, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers. Advances in therapy 39 (4) (2022)
Pablo Zubiaur, Francisco Abad-Santos
Association Studies in Clinical Pharmacogenetics. Pharmaceutics 15 (1) (2022)
Diana María Campodónico, Pablo Zubiaur, Paula Soria-Chacartegui, Ana Casajús, Gonzalo Villapalos-García, Marcos Navares-Gómez, Antía Gómez-Fernández, Raúl Parra-Garcés, Gina P Mejía-Abril, Manuel Román, Samuel Martín-Vílchez, Dolores Ochoa, Francisco Abad-Santos
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride. Clinical and translational science 15 (11) (2022)
Gonzalo Villapalos-García, Pablo Zubiaur, Rebeca Rivas-Durán, Pilar Campos-Norte, Cristina Arévalo-Román, Marta Fernández-Rico, Lucio García-Fraile Fraile, Paula Fernández-Campos, Paula Soria-Chacartegui, Sara Fernández de Córdoba-Oñate, Pablo Delgado-Wicke, Elena Fernández-Ruiz, Isidoro González-Alvaro, Jesús Sanz, Francisco Abad-Santos, Ignacio De Los Santos
Transmembrane protease serine 2 ( TMPRSS2 ) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity. Life science alliance 5 (10) (2022)
Yi-Han Chien, Gudrun Würthwein, Pablo Zubiaur, Bianca Posocco, María Angeles Pena Pardo, Alberto M Borobia, Sara Gagno, Francisco Abad-Santos, Georg Hempel
Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg. Cancer chemotherapy and pharmacology 90 (2) (2022)
Alejandra Reolid, Antonio Sahuquillo-Torralba, Ancor Sanz-García, Rafael Botella-Estrada, Ester Muñoz-Aceituno, Mar Llamas Velasco, Jorge García-Martínez, Esteban Daudén, Francisco Abad-Santos, María C Ovejero-Benito
CNVs Associated with Different Clinical Phenotypes of Psoriasis and Anti-TNF-Induced Palmoplantar Pustulosis. Journal of personalized medicine 12 (9) (2022)
Pablo Zubiaur, David Nicolás Prósper-Cuesta, Jesús Novalbos, Gina P Mejía-Abril, Marcos Navares-Gómez, Gonzalo Villapalos-García, Paula Soria-Chacartegui, Francisco Abad-Santos
Patients' Perceptions of Pharmacogenetic Testing and Access to Their Results: State of the Art in Spain and Systematic Review. Journal of personalized medicine 12 (2) (2022)
Pablo Zubiaur, Francisco Abad-Santos
Use of pharmacogenetics for benzodiazepine prescription: state of the art and expectations. Pharmacogenomics 23 (18) (2022)
María C Ovejero-Benito, Dolores Ochoa, Teresa Enrique-Benedito, Miriam Del Peso-Casado, Pablo Zubiaur, Marcos Navares, Manuel Román, Francisco Abad-Santos
Pharmacogenetics of Donepezil and Memantine in Healthy Subjects. Journal of personalized medicine 12 (5) (2022)
Pablo Zubiaur, Francisco Abad-Santos
Association Studies in Clinical Pharmacogenetics. Pharmaceutics 15 (1) (2022)
Pablo Zubiaur, Miriam Matas, Samuel Martín-Vílchez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Laura Figueiredo-Tor, Sofía Calleja, Marcos Navares-Gómez, Alejandro de Miguel, Jesús Novalbos, Gina P Mejía-Abril, Sergio Luquero-Bueno, Manuel Román, Dolores Ochoa, Francisco Abad-Santos
Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. Pharmaceutics 14 (10) (2022)
Ana Marcos-Jimenez, Daniela Claudino Carvoeiro, Nora Ruef, Carlos Cuesta-Mateos, Emilia Roy-Vallejo, Valle Gómez-García de Soria, Claudio Laganá, Lourdes Del Campo, Pablo Zubiaur, Gonzalo Villapalos-García, Francisco Abad-Santos, Jens V Stein, Cecilia Muñoz-Calleja
Dasatinib-induced spleen contraction leads to transient lymphocytosis. Blood advances (2022)
Pablo Zubiaur, Francisco Abad-Santos
Association Studies in Clinical Pharmacogenetics. Pharmaceutics 15 (1) (2022)
Gonzalo Villapalos-García, Pablo Zubiaur, Rebeca Rivas-Durán, Pilar Campos-Norte, Cristina Arévalo-Román, Marta Fernández-Rico, Lucio García-Fraile Fraile, Paula Fernández-Campos, Paula Soria-Chacartegui, Sara Fernández de Córdoba-Oñate, Pablo Delgado-Wicke, Elena Fernández-Ruiz, Isidoro González-Alvaro, Jesús Sanz, Francisco Abad-Santos, Ignacio De Los Santos
Correction: Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity and sex are the primary predictors of Covid-19 severity. Life science alliance 5 (10) (2022)
Pablo Zubiaur, Francisco Abad-Santos
Association Studies in Clinical Pharmacogenetics. Pharmaceutics 15 (1) (2022)
Pablo Zubiaur, Gina P Mejía-Abril, Marcos Navares-Gómez, Gonzalo Villapalos-García, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Dolores Ochoa, Francisco Abad-Santos
PriME-PGx: La Princesa University Hospital Multidisciplinary Initiative for the Implementation of Pharmacogenetics. Journal of clinical medicine 10 (17) (2021)
Paula Soria-Chacartegui, Gonzalo Villapalos-García, Luis A López-Fernández, Marcos Navares-Gómez, Gina P Mejía-Abril, Francisco Abad-Santos, Pablo Zubiaur
Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase ( DPYD ) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study. Pharmaceutics 13 (12) (2021)
Pilar García Alfonso, Miriam Saiz-Rodriguez, R Mondéjar, J Salazar, D Páez, Alberto M Borobia, M J Safont, I García-García, R Colomer, X García-González, M J Herrero, L A López-Fernández, Francisco Abad-Santos
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
Pablo Zubiaur, Paula Fernández-Campos, Marcos Navares-Gómez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Manuel Román, Gina P Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. Pharmaceutics 13 (10) (2021)
Hoi Yan Tong, Alberto M Borobia, Quintana Díaz Manuel, Sara Fabra, Manuel González-Viñolis, Carmen Fernández-Capitán, María A Rodriguez-Dávila, Alicia Lorenzo, Ana María López-Parra, Nuria Ruiz-Giménez, Francisco Abad-Santos, Carmen Suarez, Olga Madridano, Jorge Francisco Gómez-Cerezo, Pilar Llamas, Carlos Baeza-Richer, Eduardo Arroyo-Pardo, Antonio J Carcas, null The Pgx-Ace Spanish Investigators Group
Acenocoumarol Pharmacogenetic Dosing Algorithm versus Usual Care in Patients with Venous Thromboembolism: A Randomised Clinical Trial. Journal of clinical medicine 10 (13) (2021)
Pablo Zubiaur, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Juan J Gordillo-Perdomo, Francisco Abad-Santos
The pharmacogenetics of treatment with olanzapine. Pharmacogenomics 22 (14) (2021)
Pablo Zubiaur, Maria Dolores Benedicto, Gonzalo Villapalos-García, Marcos Navares-Gómez, Gina Mejía-Abril, Manuel Román, Samuel Martín-Vílchez, Dolores Ochoa, Francisco Abad-Santos
SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability. Journal of personalized medicine 11 (3) (2021)
Pablo Zubiaur, Lisa A Kneller, Dolores Ochoa, Gina P Mejía-Abril, Miriam Saiz-Rodriguez, Alberto M Borobia, Dora Koller, Irene García García, Marcos Navares-Gómez, Georg Hempel, Francisco Abad-Santos
Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics 60 (2) (2021)
Diana Grajales, Patricia Vázquez, Mónica Ruíz-Rosario, Eva Tudurí, Mercedes Mirasierra, Vítor Ferreira, Ana Belén Hitos, Dora Koller, Pablo Zubiaur, Juan C Cigudosa, Francisco Abad-Santos, Mario Vallejo, Iván Quesada, Boaz Tirosh, Gil Leibowitz, Ángela M Valverde
The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice. Diabetologia 65 (3) (2021)
Miriam Saiz-Rodriguez, Dolores Ochoa, Manuel Román, Pablo Zubiaur, Dora Koller, Gina Mejía, Francisco Abad-Santos
Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics. Pharmacogenomics 21 (10) (2020)
Mar Llamas Velasco, Alejandra Reolid, Ancor Sanz-García, Lola Alonso, Jorge García-Martínez, P Sánchez-Jiménez, Ester Muñoz-Aceituno, Esteban Daudén, Francisco Abad-Santos, María C Ovejero-Benito
Methylation in psoriasis. Does sex matter? Journal of the European Academy of Dermatology and Venereology : JEADV 35 (2) (2020)
Pablo Zubiaur, Miriam Saiz-Rodríguez, Dolores Ochoa, Marcos Navares-Gómez, Gina Mejía, Manuel Román, Dora Koller, Paula Soria-Chacartegui, Susana Almenara, Francisco Abad-Santos
Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran. Advances in therapy 37 (8) (2020)
Dolores Ochoa, Manuel Román, Teresa Cabaleiro, Miriam Saiz-Rodríguez, Gina Mejía, Francisco Abad-Santos
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole. BMC pharmacology & toxicology 21 (1) (2020)
Ester Muñoz-Aceituno, Luisa Martos-Cabrera, María Carmen Ovejero-Benito, Alejandra Reolid, Francisco Abad-Santos, Esteban Daudén
Pharmacogenetics Update on Biologic Therapy in Psoriasis. Medicina (Kaunas, Lithuania) 56 (12) (2020)
Dora Koller, Susana Almenara, Gina Mejía, Miriam Saiz-Rodríguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Marcos Navares-Gómez, Elena Santos-Molina, Elena Pintos-Sánchez, Francisco Abad-Santos
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics. Advances in therapy 38 (2) (2020)
Maria Stella Calafato, Isabelle Austin-Zimmerman, Johan H Thygesen, Mani Sairam, Antonio Metastasio, Louise Marston, Francisco Abad-Santos, Anjali Bhat, Jasmine Harju-Seppänen, Haritz Irizar, Eirini Zartaloudi, Elvira Bramon
The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: a systematic review and meta-analysis. The pharmacogenomics journal 20 (5) (2020)
María Angeles Pena Pardo, Javier Muriel, Miriam Saiz-Rodriguez, Alberto M Borobia, Francisco Abad-Santos, Jesús Frías, Ana María Peiró
Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects. Clinical drug investigation 40 (7) (2020)
Dora Koller, Susana Almenara, Gina P Mejía-Abril, Miriam Saiz-Rodriguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Aneta Wojnicz, Samuel Martín, Daniel Romero-Palacián, Marcos Navares-Gómez, Francisco Abad-Santos
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial. Human psychopharmacology 36 (1) (2020)
Miriam Saiz-Rodriguez, Susana Almenara, Marcos Navares-Gómez, Dolores Ochoa, Manuel Román, Pablo Zubiaur, Dora Koller, María Santos, Gina P Mejía-Abril, Alberto M Borobia, Cristina Rodríguez-Antona, Francisco Abad-Santos
Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates. Biomedicines 8 (4) (2020)
Pablo Zubiaur, Dora Koller, Miriam Saiz-Rodriguez, Marcos Navares-Gómez, Francisco Abad-Santos
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Clinical and translational science 13 (6) (2020)
Pablo Zubiaur, Miriam Saiz-Rodríguez, Francisco Abad-Santos
Author's Response to: 'Letter to the Editor in Response to: "Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally"'. Advances in therapy 37 (2) (2019)
Miriam Saiz-Rodriguez, Dolores Ochoa, Carmen Belmonte, Manuel Román, Danilo Vieira de Lara, Pablo Zubiaur, Dora Koller, Gina Mejía, Francisco Abad-Santos
Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics. Journal of psychopharmacology (Oxford, England) 33 (4) (2019)
Pablo Zubiaur, Dolores Ochoa, Mª Ángeles Gálvez, Miriam Saiz-Rodriguez, Manuel Román, Mónica Aguilar, Itziar de Pablo, Dora Koller, Francisco Abad-Santos
Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally. Advances in therapy 36 (10) (2019)
Esperanza González-Rojano, Julio Marcotegui, Dolores Ochoa, Manuel Román, Covadonga Álvarez, John Gordon, Francisco Abad-Santos, Alfredo Garcia-Arieta
Investigation on the Existence of Sex-By-Formulation Interaction in Bioequivalence Trials. Clinical pharmacology and therapeutics 106 (5) (2019)
Pablo Zubiaur, Miriam Saiz-Rodriguez, Dolores Ochoa, Carmen Belmonte, Manuel Román, Gina Mejía, Samuel Martín-Vilchez, Francisco Abad-Santos
Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers. The pharmacogenomics journal 20 (2) (2019)
María C Ovejero-Benito, T Cabaleiro, Ancor Sanz-García, Mar Llamas Velasco, Miriam Saiz-Rodriguez, R Prieto-Pérez, M Talegón, M Román, D Ochoa, A Reolid, Esteban Daudén, Francisco Abad-Santos
Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis. The British journal of dermatology 178 (3) (2018)
María C Ovejero-Benito, Ester Muñoz-Aceituno, Alejandra Reolid, Miriam Saiz-Rodríguez, Francisco Abad-Santos, Esteban Daudén
Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis. American journal of clinical dermatology 19 (2) (2018)
Dora Koller, Carmen Belmonte, Rubin Lubomirov, Miriam Saiz-Rodriguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Antonio Carcas, Aneta Wojnicz, Francisco Abad-Santos
Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects. Journal of psychopharmacology (Oxford, England) 32 (11) (2018)
Clara I Gomez-Sanchez, Juan J Carballo, Rosa Riveiro-Alvarez, Victor Soto-Insuga, Maria Rodrigo, Ignacio Mahillo-Fernandez, Francisco Abad-Santos, Rafael Dal-Ré, Carmen Ayuso
Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects. Scientific reports 7 (1) (2017)

Francisco Abad-Santos.css-eqlu8i{font-size:small;padding-left:4px;} (F Abad-Santos)

Publication Activity (10 Years)

Top Topics

Top Venues

Francisco Abad-Santos (F Abad-Santos)